News
Shares of Hims & Hers tumbled 12% in after-hours trading Monday after the company's second-quarter revenue missed Wall Street ...
Hims & Hers Health's Q2 revenue miss and decelerating growth triggered a stock drop. Find out why I maintain a 'Buy' rating ...
Shares of telehealth firm Hims & Hers fell as much as 5% on Tuesday after the company reported weaker-than-expected second-quarter revenue, hurt by a loss of subscribers in its weight-loss treatment ...
Analysts have set 12-month price targets for Hims & Hers Health, revealing an average target of $51.0, a high estimate of $65.00, and a low estimate of $40.00. Marking an increase of 4.79%, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback